Application Value of miRNA-182 as a Biomarker for Cancer Diagnosis: a Systematic Review with Meta-Analysis

References

• Shamsizadeh S , Goliaei S , Razaghi Moghadam Z . CAMIRADA: cancer microRNA association discovery algorithm, a case study on breast cancer. J. Biomed. Informat. 94, 103180 (2019).
   PubMed Web of Science ®Google Scholar
• Le DH . Network-based ranking methods for prediction of novel disease associated microRNAs. Computat. Biol. Chem. 58, 139–148 (2015).
   PubMed Web of Science ®Google Scholar
• Yao L , Zhou Y , Sui Z et al. HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells. EBioMedicine 48, 117–129 (2019).
   PubMed Web of Science ®Google Scholar
• Sur S , Steele R , Shi X , Ray RB . miRNA-29b inhibits prostate tumor growth and induces apoptosis by increasing Bim expression. Cells 8(11), 1455 (2019).
   PubMed Web of Science ®Google Scholar
• Mollaei H , Safaralizadeh R , Rostami Z . MicroRNA replacement therapy in cancer. J. Cell. Physiol. 234(8), 12369–12384 (2019).
   PubMed Web of Science ®Google Scholar
• Krol J , Loedige I , Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11(9), 597–610 (2010).
   PubMed Web of Science ®Google Scholar
• Ke R , Lv L , Zhang S , Zhang F , Jiang Y . Functional mechanism and clinical implications of microRNA-423 in human cancers. Cancer Med. 9(23), 9036–9051 (2020).
   PubMed Web of Science ®Google Scholar
• Wu CJ , Lu LF . MicroRNA in immune regulation. Curr. Topics Microbiol. Immunol. 410, 249–267 (2017).
   PubMed Web of Science ®Google Scholar
• Marzagalli M , Ebelt ND , Manuel ER . Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment. Semin. Cancer Biol. 59, 236–250 (2019).
   PubMed Web of Science ®Google Scholar
• Schwarzenbach H , Nishida N , Calin GA , Pantel K . Clinical relevance of circulating cell-free microRNAs in cancer. Nat. Rev. Clin. Oncol. 11(3), 145–156 (2014).
   PubMed Web of Science ®Google Scholar
• Lagos-Quintana M , Rauhut R , Meyer J , Borkhardt A , Tuschl T . New microRNAs from mouse and human. RNA (NY) 9(2), 175–179 (2003).
   PubMed Web of Science ®Google Scholar
• Lim LP , Glasner ME , Yekta S , Burge CB , Bartel DP . Vertebrate microRNA genes. Science (NY) 299(5612), 1540 (2003).
   PubMed Web of Science ®Google Scholar
• Dang X , He B , Ning Q , Liu Y , Chang Y , Chen M . Suppression of TRIM8 by microRNA-182-5p restricts tumor necrosis factor-α-induced proliferation and migration of airway smooth muscle cells through inactivation of NF-κb. Int. Immunopharmacol. 83, 106475 (2020).
   PubMed Web of Science ®Google Scholar
• Yan S , Wang H , Chen X et al. MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C. Cancer Lett. 488, 18–26 (2020).
   PubMed Web of Science ®Google Scholar
• Li X , Zhang X , Zhang Q , Lin R . miR-182 contributes to cell proliferation, invasion and tumor growth in colorectal cancer by targeting DAB2IP. Int. J. Biochem. Cell Biol. 111, 27–36 (2019).
   PubMed Web of Science ®Google Scholar
• Gregory DJ , Kramnik I , Kobzik L . Protection of macrophages from intracellular pathogens by miR-182-5p mimic-a gene expression meta-analysis approach. FEBS J. 285(2), 244–260 (2018).
   PubMed Web of Science ®Google Scholar
• Bahrami A , Aledavood A , Anvari K et al. The prognostic and therapeutic application of microRNAs in breast cancer: tissue and circulating microRNAs. J. Cell. Physiol. 233(2), 774–786 (2018).
   PubMed Web of Science ®Google Scholar
• Li Y , Zhang H , Gong H et al. miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene. J. Exp. Clin. Cancer Res. 37(1), 141 (2018).
   PubMedGoogle Scholar
• Jin Y , Zhang ZL , Huang Y , Zhang KN , Xiong B . MiR-182-5p inhibited proliferation and metastasis of colorectal cancer by targeting MTDH. Eur. Rev. Med. Pharmacol. Sci. 23(4), 1494–1501 (2019).
   PubMed Web of Science ®Google Scholar
• Hu J , Lv G , Zhou S et al. The downregulation of MiR-182 Is associated with the growth and invasion of osteosarcoma cells through the regulation of TIAM1 expression. PLOS ONE 10(5), e0121175 (2015).
   PubMed Web of Science ®Google Scholar
• Chen G , Yu L , Dong H , Liu Z , Sun Y . MiR-182 enhances radioresistance in non-small cell lung cancer cells by regulating FOXO3. Clin. Exp. Pharmacol. Physiol. 46(2), 137–143 (2019).
   PubMed Web of Science ®Google Scholar
• Arya D , Sachithanandan SP , Ross C , Palakodeti D , Li S , Krishna S . miRNA182 regulates percentage of myeloid and erythroid cells in chronic myeloid leukemia. Cell Death Dis. 8(1), e2547 (2017).
   PubMedGoogle Scholar
• Cao MQ , You AB , Zhu XD et al. miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. J. Hematol. Oncol. 11(1), 12 (2018).
   PubMedGoogle Scholar
• Li Z , Zhang L , Liu Z et al. miRNA-182 regulated MTSS1 inhibits proliferation and invasion in glioma Cells. J. Cancer 11(19), 5840–5851 (2020).
   PubMed Web of Science ®Google Scholar
• Luo Y , Hou WT , Zeng L et al. Progress in the study of markers related to glioma prognosis. Eur. Rev. Med. Pharmacol. Sci. 24(14), 7690–7697 (2020).
   PubMed Web of Science ®Google Scholar
• Strumidło A , Skiba S , Scott RJ , Lubiński J . The potential role of miRNAs in therapy of breast and ovarian cancers associated with BRCA1 mutation. Hered. Cancer Clin. Pract. 15, 15 (2017).
   PubMed Web of Science ®Google Scholar
• Soraya H , Sani NA , Jabbari N , Rezaie J . Metformin increases exosome biogenesis and secretion in U87 MG human glioblastoma cells: a possible mechanism of therapeutic resistance. Arch. Med. Res. 52(2), 151–162 (2021).
   PubMed Web of Science ®Google Scholar
• Yang L , Dou Y , Sui Z et al. Upregulated miRNA-182-5p expression in tumor tissue and peripheral blood samples from patients with non-small cell lung cancer is associated with downregulated Caspase 2 expression. Exp. Ther. Med. 19(1), 603–610 (2020).
   PubMed Web of Science ®Google Scholar
• Xiao D , Xie J , Wu S . MicroRNA-182 is a potential biomarker for prognosis of gastric cancer: a protocol for meta-analysis and bioinformatics analysis. Medicine (Baltimore) 100(22), e25830 (2021).
   PubMed Web of Science ®Google Scholar
• Wang M , Wang Y , Zang W et al. Downregulation of microRNA-182 inhibits cell growth and invasion by targeting programmed cell death 4 in human lung adenocarcinoma cells. Tumour Biol. 35(1), 39–46 (2014).
   PubMedGoogle Scholar
• Guo Y , Qiao X , Zhu L , Song R . MicroRNA-182-5p modulates oral squamous cell carcinoma migration and invasion via targeting MTSS1 gene. Pathol. Oncol. Res. 26(2), 1007–1013 (2020).
   PubMed Web of Science ®Google Scholar
• Golbakhsh MR , Boddouhi B , Hatami N et al. Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcoma. Arch. Med. Sci. 13(6), 1352–1356 (2017).
   PubMed Web of Science ®Google Scholar
• Soheilifar MH , Vaseghi H , Seif F et al. Concomitant overexpression of mir-182-5p and mir-182-3p raises the possibility of IL-17-producing Treg formation in breast cancer by targeting CD3d, ITK, FOXO1, and NFATs: a meta-analysis and experimental study. Cancer Sci. 112(2), 589–603 (2021).
   PubMed Web of Science ®Google Scholar
• Chen X , Ba Y , Ma L et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18(10), 997–1006 (2008).
   PubMed Web of Science ®Google Scholar
• Favier A , Rocher G , Larsen AK et al. MicroRNA as epigenetic modifiers in endometrial cancer: a systematic review. Cancers (Basel) 13(5), 1137 (2021).
   PubMed Web of Science ®Google Scholar
• Hayes J , Peruzzi PP , Lawler S . MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol. Med. 20(8), 460–469 (2014).
   PubMed Web of Science ®Google Scholar
• Ghizoni JS , Nichele R , De Oliveira MT , Pamato S , Pereira JR . The utilization of saliva as an early diagnostic tool for oral cancer: microRNA as a biomarker. Clin. Transl. Oncol. 22(6), 804–812 (2020).
   PubMed Web of Science ®Google Scholar
• Yang B , Mallett S , Takwoingi Y et al. QUADAS-C: a tool for assessing risk of bias in comparative diagnostic accuracy studies. Ann. Intern. Med. 174(11), 1592–1599 (2021).
   PubMed Web of Science ®Google Scholar
• Liang M , Yu S , Tang S et al. A panel of plasma exosomal miRNAs as potential biomarkers for differential diagnosis of thyroid nodules. Front Genet. 11, 449 (2020).
   PubMed Web of Science ®Google Scholar
• Brinzan C , Aschie M , Matei E , Mitroi A , Cozaru G . Molecular expression profiles of selected microRNAs in colorectal adenocarcinoma in patients from south-eastern part of Romania. Medicine (Baltimore) 98(47), e18122 (2019).
   PubMed Web of Science ®Google Scholar
• Liu X , Xu T , Hu X et al. Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer. Cancer Manag. Res. 10, 857–865 (2018).
   PubMed Web of Science ®Google Scholar
• Lucas Grzelczyk W , Szemraj J , Kwiatkowska S , Jozefowicz-Korczynska M . Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC). Diagn. Pathol. 14(1), 49 (2019).
   PubMed Web of Science ®Google Scholar
• Szczyrek M , Kuźnar-Kamińska B , Grenda A et al. Diagnostic value of plasma expression of microRNAs complementary to Drosha and Dicer in lung cancer patients. Eur. Rev. Med. Pharmacol. Sci. 23(9), 3857–3866 (2019).
   PubMed Web of Science ®Google Scholar
• Zou JG , Ma LF , Li X et al. Circulating microRNA array (miR-182, 200b and 205) for the early diagnosis and poor prognosis predictor of non-small cell lung cancer. Eur. Rev. Med. Pharmacol. Sci. 23(3), 1108–1115 (2019).
   PubMed Web of Science ®Google Scholar
• Zhu W , Zhou K , Zha Y et al. Diagnostic value of serum miR-182, miR-183, miR-210, and miR-126 levels in patients with early-stage non-small cell lung cancer. PLOS ONE 11(4), e0153046 (2016).
   PubMed Web of Science ®Google Scholar
• Mohamed WA , Schaalan MF , Ramadan B . The expression profiling of circulating miR-204, miR-182, and lncRNA H19 as novel potential biomarkers for the progression of peptic ulcer to gastric cancer. J. Cell. Biochem. 120(8), 13464–13477 (2019).
   PubMed Web of Science ®Google Scholar
• Tamiya H , Mitani A , Saito A et al. Exosomal microRNA expression profiling in patients with lung adenocarcinoma-associated malignant pleural effusion. Anticancer Res. 38(12), 6707–6714 (2018).
   PubMed Web of Science ®Google Scholar
• Ali OS , Shabayek MI , Seleem MM , Abdelaziz HG , Makhlouf DO . MicroRNAs 182 and 375 sera expression as prognostic biochemical markers in breast cancer. Clin. Breast Cancer 18(6), e1373–e1379 (2018).
   PubMed Web of Science ®Google Scholar
• Kandil NS , Kandil LS , Mohamed R et al. The role of miRNA-182 and FOXO3 expression in breast cancer. Asian Pac. J. Cancer Prev. 23(10), 3361–3370 (2022).
   PubMedGoogle Scholar
• Shaheen NMH , Zayed N , Riad NM et al. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients. Virus Res. 255, 77–84 (2018).
   PubMed Web of Science ®Google Scholar
• Liu HN , Wu H , Chen YJ et al. Serum microRNA signatures and metabolomics have high diagnostic value in hepatocellular carcinoma. Oncotarget 8(65), 108810–108824 (2017).
   PubMedGoogle Scholar
• Chen L , Chu F , Cao Y , Shao J , Wang F . Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Tumour Biol. 36(10), 7439–7447 (2015).
   PubMedGoogle Scholar
• Hu YW , Chen SY , Xie YH . Application of miR-182 for determination of glucocorticoid-resistant patients with lymphoid malignancy. Zhongguo Shi Yan Xue Ye Xue Za Zhi 25(3), 781–785 (2017).
   PubMedGoogle Scholar
• Xiaoli Z , Yawei W , Lianna L , Haifeng L , Hui Z . Screening of target genes and regulatory function of miRNAs as prognostic indicators for prostate cancer. Med. Sci. Monit. 21, 3748–3759 (2015).
   PubMed Web of Science ®Google Scholar
• Chen Q , Yang L , Xiao Y , Zhu J , Li Z . Circulating microRNA-182 in plasma and its potential diagnostic and prognostic value for pancreatic cancer. Med. Oncol. 31(11), 225 (2014).
   PubMed Web of Science ®Google Scholar
• Lijmer JG , Bossuyt PM , Heisterkamp SH . Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat. Med. 21(11), 1525–1537 (2002).
   PubMed Web of Science ®Google Scholar
• Sun Z , Shi K , Yang S et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer 17(1), 147 (2018).
   PubMed Web of Science ®Google Scholar
• Ali Syeda Z , Langden SSS , Munkhzul C , Lee M , Song SJ . Regulatory mechanism of MicroRNA expression in cancer. Int. J. Mol. Sci. 21(5), 1723 (2020).
   PubMed Web of Science ®Google Scholar
• Manikkath J , Jishnu PV , Wich PR , Manikkath A , Radhakrishnan R . Nanoparticulate strategies for the delivery of miRNA mimics and inhibitors in anticancer therapy and its potential utility in oral submucous fibrosis. Nanomedicine (Lond.) 17(3), 181–195 (2022).
   PubMed Web of Science ®Google Scholar
• Zhang L , Liao Y , Tang L . MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer. J. Exp. Clin. Cancer Res. 38(1), 53 (2019).
   PubMed Web of Science ®Google Scholar
• Van Der Ree MH , Van Der Meer AJ , De Bruijne J et al. Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients. Antiviral Res. 111, 53–59 (2014).
   PubMed Web of Science ®Google Scholar
• Shimomura A , Shiino S , Kawauchi J et al. Novel combination of serum microRNA for detecting breast cancer in the early stage. Cancer Sci. 107(3), 326–334 (2016).
   PubMed Web of Science ®Google Scholar
• Wu KL , Tsai YM , Lien CT , Kuo PL , Hung AJ . The roles of microRNA in lung cancer. Int. J. Mol. Sci. 20(7), 1611 (2019).
   PubMed Web of Science ®Google Scholar